For laboratory research use only. Not for human or veterinary use. Read our research-use policy

Melanocortin peptides

PT-141 research peptide

PT-141 is bremelanotide, a synthetic cyclic heptapeptide analogue of alpha-MSH with high affinity for the melanocortin 4 receptor.

1 size · from $16.99 · 1 in stock · flat $24.95 US shipping per order

Sizes, prices and availability

PT-141 sizes and prices
SizeSKUStated purityBatch COAPriceAvailability
10 mg P41 Not yet provided Not yet provided $16.99 In stock

Prices and stock are checked at build time and refreshed live in your browser. Orders are US only for a flat $24.95 shipping fee. Shipping details

About PT-141

PT-141 is the development name of bremelanotide. Dhillon and Keam (2019) describe bremelanotide as a synthetic peptide analogue of the neuropeptide hormone alpha-MSH with high affinity for the melanocortin 4 receptor, and report that it has been approved in the USA (as Vyleesi) for a defined clinical indication in premenopausal women.

Hedlund (2004) reports that PT-141 was developed from an earlier analogue, PT-14. Cipriani et al. (2023) review the proposed mechanism of action, pharmacokinetics, efficacy and safety data from the clinical trials of bremelanotide. Those are clinical findings on an approved medicine and are not claims about this research material.

What the published literature covers

  • Dhillon and Keam (2019) summarise the development milestones that led to approval.
  • Hedlund (2004) reports the early development of PT-141.
  • Cipriani et al. (2023) review proposed mechanism, pharmacokinetics, efficacy and safety.

Vial arithmetic

The peptide reconstitution calculator converts a vial size, diluent volume and target amount into concentration, syringe units and draws per vial. Volumes convert to syringe units with the syringe units converter. It does arithmetic only and does not suggest any amount.

FAQ

Is PT-141 the same as bremelanotide?

Yes. PubChem lists PT-141 as a synonym of bremelanotide (CID 9941379, C50H68N14O10, 1025.2 g/mol).

How does PT-141 differ from melanotan II?

Both are cyclic heptapeptides with the same ring residues. The formulas differ by exactly the change of a C-terminal amide (melanotan II, C50H69N15O9) to a free carboxylic acid (PT-141, C50H68N14O10), about 1 Da.

What sizes of PT-141 does Covalume list?

Covalume lists PT-141 in one size: 10 mg. Each size shows its price and live stock status in the variants table on this page.

How is the purity of PT-141 documented?

Each listing shows the purity the supplier states, labelled (supplier), and the batch Certificate of Analysis field reads "Not yet provided" until a batch-specific document is on file. Our guide to reading a Certificate of Analysis explains what HPLC and mass-spectrometry results show.

References

  1. Dhillon S, Keam SJ (2019). Bremelanotide: First Approval. Drugs 79:1599-1606. PubMed 31429064 · DOI
  2. Hedlund P (2004). PT-141 Palatin. Curr Opin Investig Drugs 5:456-62. PubMed 15134289
  3. Cipriani S, Alfaroli C, Maseroli E, et al. (2023). An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder. Expert Opin Pharmacother 24:15-21. PubMed 36242769 · DOI

Identity values are from PubChem (CID 9941379) and the cited papers; for linear peptides the mass was also checked against the sequence. Last updated 2026-11-18.

Related research peptides

From the research library